243 related articles for article (PubMed ID: 22104698)
1. Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.
Wang C; Hu ZQ; Chu M; Wang Z; Zhang WG; Wang LZ; Li CG; Wang JS
Clin Neurol Neurosurg; 2012 Apr; 114(3):241-8. PubMed ID: 22104698
[TBL] [Abstract][Full Text] [Related]
2. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
Miller M; Chen S; Woodliff J; Kansra S
Endocrinology; 2008 Aug; 149(8):4158-67. PubMed ID: 18450960
[TBL] [Abstract][Full Text] [Related]
3. Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines.
Selek A; Halbutoğulları ZSU; Aydemir Çİ; Cetinarslan B; Canturk Z; Tarkun I; Erman G; Subaşı C; Erdal K
Mol Neurobiol; 2023 May; 60(5):2442-2454. PubMed ID: 36662360
[TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line.
Lv H; Li C; Gui S; Sun M; Li D; Zhang Y
J Neurooncol; 2011 Apr; 102(2):237-45. PubMed ID: 20700755
[TBL] [Abstract][Full Text] [Related]
5. The prolactin-release inhibitor paeoniflorin suppresses proliferation and induces apoptosis in prolactinoma cells via the mitochondria-dependent pathway.
Wei Y; Zhou X; Ren L; Wang C; Li Y
J Cell Biochem; 2018 Jul; 119(7):5704-5714. PubMed ID: 29388711
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Adhami VM; Afaq F; Ahmad N
Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
10. Up- and Down-regulated Leukemia-related Protein 16 Affects ERα Expression and Prolactin Secretion by GH3 Cells.
Su X; Wu ZQ; Yang XJ; Wang AP; Zhao K; Wu TG; Sun Y; Sun J; Chang ZY; Guo XY; Guo QH; Mu YM
Biomed Environ Sci; 2017 Dec; 30(12):938-942. PubMed ID: 29335066
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway.
Wang C; Bai M; Wang X; Tan C; Zhang D; Chang L; Li G; Xie L; Su J; Wen Y
Mol Med Rep; 2018 Oct; 18(4):4037-4041. PubMed ID: 30106152
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line.
Bulayeva NN; Wozniak AL; Lash LL; Watson CS
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E388-97. PubMed ID: 15494610
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
Wang W; Knosp E; Tai G; Zhao Y; Liang Q; Guo Y
Int J Clin Exp Pathol; 2014; 7(12):8498-505. PubMed ID: 25674214
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol modulates the expression of PTGS2 and cellular proliferation in the normal rat endometrium in an AKT-dependent manner.
Singh M; Parent S; Leblanc V; Asselin E
Biol Reprod; 2011 May; 84(5):1045-52. PubMed ID: 21248286
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
[TBL] [Abstract][Full Text] [Related]
19. Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Cao L; Gao H; Gui S; Bai G; Lu R; Wang F; Zhang Y
J Neurooncol; 2014 Feb; 116(3):523-31. PubMed ID: 24407733
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.
Kim AL; Zhu Y; Zhu H; Han L; Kopelovich L; Bickers DR; Athar M
Exp Dermatol; 2006 Jul; 15(7):538-46. PubMed ID: 16761963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
